Merz Pharma GmbH & Co. KGaA
↗Frankfurt am Main, Germany
Merz Pharma is a global, family-owned pharmaceutical company headquartered in Frankfurt, Germany, with a history dating back to 1908. The company operates through three independent business units: Merz Aesthetics (medical aesthetics), Merz Therapeutics (specialty neurology and movement disorders), and Merz Lifecare (consumer health and beauty).
Merz Therapeutics, in particular, focuses on addressing unmet needs in patients suffering from neurological conditions, such as movement disorders (e.g., dystonia, spasticity) and neurodegenerative diseases. The company is known for its patient-centric approach, leveraging its expertise in neurotoxins and specialty pharmaceuticals to develop and commercialize innovative treatment standards globally.
CLASSIFICATION
Company Type:Biotech
Therapeutic Areas:
Industry:Pharmaceuticals
Sub-Industry:Neurology, Medical Aesthetics, Consumer Health
SIZE & FINANCIALS
Employees:1001-5000
Revenue:$1B-$2B
Founded:1908
Ownership:private
Status:operating
PIPELINE
Stage:Phase 3
Lead Drug Stage:Commercial
Modalities:Small molecule, Botulinum neurotoxin
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Subsidiaries:Merz Aesthetics GmbH, Merz Therapeutics GmbH, Merz Lifecare GmbH
Key Partnerships:Teijin Limited (commercialization of Xeomin in Japan)
COMPETITION
Position:Leader
Competitors:Allergan (AbbVie), Ipsen, Galderma
LEADERSHIP
Key Executives:
Philip Burchard - CEO
Hans-Jörg Bergler - COO
LINKS
Website:merz.com
LinkedIn:LinkedIn Profile
⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Merz Pharma GmbH & Co. KGaA and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Merz Pharma GmbH & Co. KGaA. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.